Ducharme is a contributor to TIME. Healthcare workers hold a tablet in front of a COVID-19 coronavirus patient during a video call with relatives at the Intensive Unit Care (ICU) of the Ramon y Cajal ...
Many patients suffer not only from respiratory symptoms due to their COVID-19 disease, but also from significantly reduced physical performance. A patent-protected tablet (CICR-NAM) developed at the ...
BENGALURU (Reuters) - Glenmark Pharmaceuticals Ltd said on Monday it would lower the price of its generic version of favipiravir, FabiFlu, to 75 rupees ($0.9983) per tablet for restricted emergency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results